Scientists hunt for prostate cancer clues in blood and urine
NCT ID NCT06144619
Summary
This study aims to find new, non-invasive ways to track prostate cancer by analyzing blood, urine, and tissue samples from patients. It will observe 500 men with different risk levels of prostate cancer who are receiving standard care. The goal is to discover biomarkers that could help doctors monitor the disease without needing as many invasive biopsies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.